T. Bourgeron, From the genetic architecture to synaptic plasticity in autism spectrum disorder, Nature Reviews Neuroscience, vol.511, issue.9, pp.551-563, 2015.
DOI : 10.1016/j.cell.2004.09.011
URL : https://hal.archives-ouvertes.fr/hal-01576592

K. S. Lam, M. G. Aman, and L. Arnold, Neurochemical correlates of autistic disorder: A review of the literature, Research in Developmental Disabilities, vol.27, issue.3, pp.254-289, 2006.
DOI : 10.1016/j.ridd.2005.03.003

D. A. Rossignol and R. E. Frye, Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis, Molecular Psychiatry, vol.53, issue.3, pp.290-314, 2012.
DOI : 10.1016/j.metabol.2003.12.025

A. Frustaci, Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses, Free Radical Biology and Medicine, vol.52, issue.10, pp.2128-2141011, 2012.
DOI : 10.1016/j.freeradbiomed.2012.03.011

R. J. Schain and D. X. Freedman, Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children, The Journal of Pediatrics, vol.58, issue.3, pp.315-32010, 1961.
DOI : 10.1016/S0022-3476(61)80261-8

G. M. Anderson, W. C. Horne, D. Chatterjee, and D. J. Cohen, The Hyperserotonemia of Autism, Annals of the New York Academy of Sciences, vol.48, issue.1 The Neurophar, pp.331-332, 1990.
DOI : 10.1007/BF01952198

M. Leboyer, Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives, Biological Psychiatry, vol.45, issue.2, pp.158-16310, 1999.
DOI : 10.1016/S0006-3223(97)00532-5

C. Pagan, The serotonin-N-acetylserotonin???melatonin pathway as a biomarker for autism spectrum disorders, Translational Psychiatry, vol.2, issue.11, p.120, 2014.
DOI : 10.1186/1740-3391-9-8

I. Nir, Brief report: Circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism, Journal of Autism and Developmental Disorders, vol.272, issue.Suppl., pp.641-65410, 1995.
DOI : 10.1176/ajp.145.2.229

G. Kulman, Evidence of pineal endocrine hypofunction in autistic children, Neuroendocrinology Lett, vol.21, pp.31-34, 2000.

S. Tordjman, G. M. Anderson, N. Pichard, H. Charbuy, and Y. Touitou, Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder, Biological Psychiatry, vol.57, issue.2, pp.134-138, 2005.
DOI : 10.1016/j.biopsych.2004.11.003

J. Melke, Abnormal melatonin synthesis in autism spectrum disorders, Molecular Psychiatry, vol.280, issue.1, pp.90-98, 2008.
DOI : 10.1002/mrdd.20023
URL : https://hal.archives-ouvertes.fr/inserm-00166901

S. Tordjman, Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder, Psychoneuroendocrinology, vol.37, issue.12, 1990.
DOI : 10.1016/j.psyneuen.2012.04.013

T. C. Erren and R. J. Reiter, Melatonin: a universal time messenger, Neuroendocrinology Lett, vol.36, pp.187-192, 2015.

J. D. Johnston and D. J. Skene, 60 YEARS OF NEUROENDOCRINOLOGY: Regulation of mammalian neuroendocrine physiology and rhythms by melatonin, Journal of Endocrinology, vol.226, issue.2, pp.187-19810, 2015.
DOI : 10.1530/JOE-15-0119

B. Claustrat, J. Brun, and G. Chazot, The basic physiology and pathophysiology of melatonin, Sleep Medicine Reviews, vol.9, issue.1, pp.11-24, 2005.
DOI : 10.1016/j.smrv.2004.08.001

T. Bourgeron, The Possible Interplay of Synaptic and Clock Genes in Autism Spectrum Disorders, Cold Spring Harbor Symposia on Quantitative Biology, vol.260, issue.1, pp.645-654020, 2007.
DOI : 10.1038/sj.mp.4001629

I. M. Andersen, J. Kaczmarska, S. G. Mc-grew, and B. A. Malow, Melatonin for Insomnia in Children With Autism Spectrum Disorders, Journal of Child Neurology, vol.29, issue.5, pp.482-48510, 2008.
DOI : 10.1093/sleep/29.12.1563

B. Wright, Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover Trial, Journal of Autism and Developmental Disorders, vol.46, issue.3, pp.175-18410, 2011.
DOI : 10.1017/S0012162204000611

B. Malow, Melatonin for Sleep in Children with Autism: A Controlled Trial Examining Dose, Tolerability, and Outcomes, Journal of Autism and Developmental Disorders, vol.32, issue.9, pp.1729-1737, 2012.
DOI : 10.1093/sleep/32.12.1566

S. W. Jang, N-acetylserotonin activates TrkB receptor in a circadian rhythm, Proc. Natl. Acad. Sci. USA, pp.3876-388110, 2010.
DOI : 10.1210/me.15.10.1748
URL : http://www.pnas.org/content/107/8/3876.full.pdf

A. Choudhury, S. Singh, G. Palit, S. Shukla, and S. Ganguly, Administration of N-acetylserotonin and melatonin alleviate chronic ketamine-induced behavioural phenotype accompanying BDNF-independent and dependent converging cytoprotective mechanisms in the hippocampus, Behavioural Brain Research, vol.297, pp.204-212027, 2016.
DOI : 10.1016/j.bbr.2015.10.027

T. Obsil, R. Ghirlando, D. C. Klein, S. Ganguly, and F. Dyda, Crystal Structure of the 14-3-3??:Serotonin N-Acetyltransferase Complex, Cell, vol.105, issue.2, pp.257-267, 2001.
DOI : 10.1016/S0092-8674(01)00316-6

E. Maronde, Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland, Journal of Pineal Research, vol.69, issue.1, pp.145-155, 2011.
DOI : 10.1097/NEN.0b013e3181db7d3c

D. Yu, miR-451 protects against erythroid oxidant stress by repressing 14-3-3??, Genes & Development, vol.24, issue.15, pp.1620-16331942110, 2010.
DOI : 10.1101/gad.1942110
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912560

A. Bergamaschi and B. S. Katzenellenbogen, Tamoxifen downregulation of miR-451 increases 14-3-3?? and promotes breast cancer cell survival and endocrine resistance, Oncogene, vol.24, issue.1, pp.39-47223, 2011.
DOI : 10.1101/gad.1942110
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175015

L. Wu, Altered Expression of 14-3-3?? Protein in Spinal Cords of Rat Fetuses with Spina Bifida Aperta, PLoS ONE, vol.16, issue.8, 2013.
DOI : 10.1371/journal.pone.0070457.t002

P. Chaste, Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders, Journal of Pineal Research, vol.1167, issue.4, pp.394-399, 2011.
DOI : 10.1111/j.1749-6632.2009.04604.x

L. Jonsson, Mutation screening of melatonin-related genes in patients with autism spectrum disorders, BMC Medical Genomics, vol.46, issue.1, pp.10-1186, 2010.
DOI : 10.1111/j.1600-079X.2008.00659.x

C. Pagan, Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with Intellectual Disability, BMC Medical Genetics, vol.3, issue.Pt 4, pp.10-1186, 2011.
DOI : 10.1371/journal.pone.0003055
URL : https://hal.archives-ouvertes.fr/inserm-00610655

H. Goubran-botros, Crystal structure and functional mapping of human ASMT, the last enzyme of the melatonin synthesis pathway, Journal of Pineal Research, vol.426, issue.1, pp.46-57, 2013.
DOI : 10.1038/nature02168

G. Cai, Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: Efficient identification of known microduplications and identification of a novel microduplication in ASMT, BMC Medical Genomics, vol.12, issue.11, pp.10-1186, 2008.
DOI : 10.1038/sj.mp.4002069
URL : https://hal.archives-ouvertes.fr/inserm-00375019

P. S. Cheah, Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3?? deficiency, Molecular Psychiatry, vol.155, issue.4, pp.451-466158, 2011.
DOI : 10.1002/ajmg.a.34072
URL : http://psasir.upm.edu.my/24411/1/Neurodevelopmental%20and%20neuropsychiatric%20behaviour%20defects%20arise%20from%2014.pdf

Y. Aghazadeh and V. Papadopoulos, The role of the 14-3-3 protein family in health, disease, and drug development, Drug Discovery Today, vol.21, issue.2, pp.278-287012, 2016.
DOI : 10.1016/j.drudis.2015.09.012

J. M. Saavedra, M. Brownstein, and J. Axelrod, A specific and sensitive enzymatic-isotopic microassay for serotonin in tissues, J. Pharmacol. Exper. Ther, vol.186, pp.508-515, 1973.

S. Ganguly, Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N-acetyltransferase mediated by phosphoserine-205, Proc. Natl. Acad. Sci. USA, pp.1222-12270406871102, 2005.
DOI : 10.1016/0006-2952(73)90196-2

T. Liu and J. Borjigin, N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night, Journal of Pineal Research, vol.278, issue.1, pp.91-96, 2005.
DOI : 10.1177/074873099129000489

J. M. Launay, N. Barré, J. L. Costa, and M. Da-prada, The melatonin pathway in blood platelets. Melatonin and the Pineal Gland. From Basic Science to Clinical Application, pp.35-40, 1993.

H. Yu, E. J. Dickson, S. R. Jung, D. S. Koh, and B. Hille, High membrane permeability for melatonin, The Journal of General Physiology, vol.18, issue.1, pp.63-7610, 2015.
DOI : 10.1113/jphysiol.2014.284208
URL : http://jgp.rupress.org/content/jgp/147/1/63.full.pdf

C. Toma, Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations, Molecular Psychiatry, vol.21, issue.11, pp.977-979, 2007.
DOI : 10.1038/sj.mp.4002069

O. J. Veatch, Genetic Variation in Melatonin Pathway Enzymes in Children with Autism Spectrum Disorder and Comorbid Sleep Onset Delay, Journal of Autism and Developmental Disorders, vol.10, issue.1, pp.100-11010, 2015.
DOI : 10.1111/j.1601-183X.2011.00684.x

B. Etain, Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder, Human Molecular Genetics, vol.21, issue.18, pp.4030-403710, 2012.
DOI : 10.1093/hmg/dds227

P. A. Geoffroy, Genetic association study of circadian genes with seasonal pattern in bipolar disorders, Scientific Reports, vol.13, issue.1, pp.10-1038, 2015.
DOI : 10.1111/gbb.12103

D. F. Kripke, Polymorphisms in melatonin synthesis pathways: possible influences on depression, Journal of Circadian Rhythms, vol.9, issue.1, pp.10-1186, 2011.
DOI : 10.1016/j.biopsych.2010.06.004
URL : http://doi.org/10.1186/1740-3391-9-8

T. Ichimura, T. Isobe, T. Okuyama, T. Yamauchi, and H. Fujisawa, ,calmodulin-dependent protein kinase II, FEBS Letters, vol.100, issue.1, pp.79-8210, 1987.
DOI : 10.1016/S0006-291X(81)80246-X

C. Toma, Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations, Molecular Psychiatry, vol.3, issue.7, pp.784-790, 2014.
DOI : 10.1038/jhg.2011.61

K. K. Jacobsen, R. Kleppe, S. Johansson, T. Zayats, and J. Haavik, Epistatic and gene wide effects in YWHA and aromatic amino hydroxylase genes across ADHD and other common neuropsychiatric disorders: Association with YWHAE, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.103, issue.6, pp.423-432, 2015.
DOI : 10.1073/pnas.0605779103
URL : http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32339/pdf

I. Voineagu, Transcriptomic analysis of autistic brain reveals convergent molecular pathology, Nature, vol.38, issue.7351, pp.380-384, 2011.
DOI : 10.1038/nature06757

D. Pinto, Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders, The American Journal of Human Genetics, vol.94, issue.5, pp.677-94018, 2014.
DOI : 10.1016/j.ajhg.2014.03.018
URL : https://hal.archives-ouvertes.fr/inserm-00986225

K. Ackermann, Characterization of Human Melatonin Synthesis Using Autoptic Pineal Tissue, Endocrinology, vol.147, issue.7, pp.3235-32422006, 2006.
DOI : 10.1210/en.2006-0043

I. P. Kema, High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients, Clinica Chimica Acta, vol.221, issue.1-2, pp.143-15810, 1993.
DOI : 10.1016/0009-8981(93)90029-4